142 related articles for article (PubMed ID: 38560081)
41. Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline.
Alanaeme CJ; Bittner V; Brown TM; Colantonio LD; Dhalwani N; Jones J; Kalich B; Exter J; Jackson EA; Levitan EB; Poudel B; Wang Z; Woodward M; Muntner P; Rosenson RS
Am Heart J Plus; 2022 Sep; 21():. PubMed ID: 37168932
[TBL] [Abstract][Full Text] [Related]
42. Optimizing lipid management in patients with acute coronary syndromes.
Pepine CJ
Am J Cardiol; 2003 Feb; 91(4A):30B-35B. PubMed ID: 12615296
[TBL] [Abstract][Full Text] [Related]
43. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
44. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
[TBL] [Abstract][Full Text] [Related]
45. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
46. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.
Barkas F; Milionis H; Kostapanos MS; Mikhailidis DP; Elisaf M; Liberopoulos E
Curr Med Res Opin; 2015 Feb; 31(2):221-8. PubMed ID: 25418708
[TBL] [Abstract][Full Text] [Related]
47. The Effect of Intensified Low Density Lipoprotein Cholesterol Reduction on Recurrent Myocardial Infarction and Cardiovascular Mortality.
Huang WC; Lin TW; Chiou KR; Cheng CC; Kuo FY; Chiang CH; Yang JS; Lin KL; Hsiao SH; Yeh TC; Mar GY; Hsiao HC; Lin SL; Chiou CW; Liu CP
Acta Cardiol Sin; 2013 Sep; 29(5):404-12. PubMed ID: 27122737
[TBL] [Abstract][Full Text] [Related]
48. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
49. Early impact of the 2018 AHA/ACC/multisociety cholesterol guideline on lipid monitoring after statin initiation.
Tunoa JA; Billups SJ; Lowe RN; Saseen JJ
J Clin Lipidol; 2020; 14(6):784-790. PubMed ID: 32978094
[TBL] [Abstract][Full Text] [Related]
50. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
[TBL] [Abstract][Full Text] [Related]
51. The prevalence of hyperlipidemia and features of lipid-lowering therapy in patients with myocardial infarction according to the Russian register of acute myocardial infarction REGION-MI.
Boytsov SA; Shakhnovich RM; Tereschenko SN; Erlikh AD; Kukava NG; Pevsner DV; Rytova YK
Kardiologiia; 2022 Jul; 62(7):12-22. PubMed ID: 35989625
[TBL] [Abstract][Full Text] [Related]
52. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
53. Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction-Impact on Tailored Lipid-Lowering Therapy at Discharge.
Marcos-Garcés V; Merenciano-González H; Martínez Mas ML; Palau P; Climent Alberola JI; Perez N; López-Bueno L; Esteban Argente MC; Valls Reig M; Muñoz Alcover R; Pradillas Contreras I; Arizón Benito A; Payá Rubio A; Ríos-Navarro C; de Dios E; Gavara J; Chorro FJ; Sanchis J; Bodi V
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202134
[TBL] [Abstract][Full Text] [Related]
54. Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines.
Levintow SN; Reading SR; Saul BC; Yu Y; Reams D; McGrath LJ; Philip K; Dluzniewski PJ; Brookhart MA
Clin Epidemiol; 2020; 12():835-845. PubMed ID: 32801921
[TBL] [Abstract][Full Text] [Related]
55. [Associations between various lipid components and premature myocardial infarction: a cross-sectional study].
Shi J; Zhang HY; Wang DY; Gao Q; Sheng L; Song PW; Zhang Y; Li Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Mar; 51(3):278-287. PubMed ID: 36925138
[No Abstract] [Full Text] [Related]
56. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
Räber L; Ueki Y; Otsuka T; Losdat S; Häner JD; Lonborg J; Fahrni G; Iglesias JF; van Geuns RJ; Ondracek AS; Radu Juul Jensen MD; Zanchin C; Stortecky S; Spirk D; Siontis GCM; Saleh L; Matter CM; Daemen J; Mach F; Heg D; Windecker S; Engstrøm T; Lang IM; Koskinas KC;
JAMA; 2022 May; 327(18):1771-1781. PubMed ID: 35368058
[TBL] [Abstract][Full Text] [Related]
57. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
Hao Q; Aertgeerts B; Guyatt G; Bekkering GE; Vandvik PO; Khan SU; Rodondi N; Jackson R; Reny JL; Al Ansary L; Van Driel M; Assendelft WJJ; Agoritsas T; Spencer F; Siemieniuk RAC; Lytvyn L; Heen AF; Zhao Q; Riaz IB; Ramaekers D; Okwen PM; Zhu Y; Dawson A; Ovidiu MC; Vanbrabant W; Li S; Delvaux N
BMJ; 2022 May; 377():e069066. PubMed ID: 35508320
[TBL] [Abstract][Full Text] [Related]
58. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
Lowenstern A; Li S; Navar AM; Virani S; Lee LV; Louie MJ; Peterson ED; Wang TY
Am Heart J; 2018 Jun; 200():118-124. PubMed ID: 29898839
[TBL] [Abstract][Full Text] [Related]
59. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
[TBL] [Abstract][Full Text] [Related]
60. Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort.
Atallah B; Khaddage R; Sadik ZG; Mallah SI; Lee-St John TJ; Alfardan S; Traina MI; Almahmeed W
Glob Heart; 2020 Feb; 15(1):12. PubMed ID: 32489785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
